openPR Logo
Press release

Peptide Based Cancer Therapeutics Market Estimated to Reach US$ 11,100 Mn by 2022

09-07-2017 02:31 PM CET | Health & Medicine

Press release from: Fact.MR

Peptide Based Cancer Therapeutics Market Estimated to Reach US$

Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug modification, stability, delivery and preclinical achievements is reflecting positively on the future prospects of the global peptide based cancer therapeutics market. Of late, an array of new peptides with encouraging preclinical results are undergoing clinical trials for treating cancer. At the same time, these new peptide are also finding application in various other therapeutic areas. Also, increasing occurrence of cancer is anticipated to be instrumental in boosting the demand for peptide based cancer therapeutics in the near future. As per WHO, over 8 million deaths were recorder globally due to cancer in 2015. Cancer remains one of the foremost causes of death around the world. Factors mentioned above are projected to make a significant influence on the global market for peptide based cancer therapeutics over the forecast period. Moreover, low potency of conventional cancer therapeutics and the adverse side-effects from these therapeutics is prompting physicians to utilise other options. This, in turn, is facilitating the adoption of new-age peptide based therapeutic drugs.


Request For Sample Report @ www.factmr.com/connectus/sample?flag=S&rep_id=179

Forecast Highlights Of Global Market For Peptide Based Cancer Therapeutics

Among regions, North America is expected to remain the most attractive market for peptide based cancer therapeutics during the forecast period. This is largely due to the existence of several prominent peptide based cancer therapeutic drug makers and an advanced healthcare infrastructure in the region. Over the next couple of years, the region’s market is projected to witness a healthy growth. Meanwhile, the market in Asia-Pacific excluding Japan (APEJ) is anticipated to register the fastest CAGR over 2022.

Based on drugs, demand for bortezomib is expected to remain relative higher as compared to other peptide based cancer therapeutic drugs. Revenues from global sales of bortezomib drugs currently commands for nearly 40% market share. Towards the end of 2022, more than US$ 4,700 Mn worth bortezomib drugs are estimated to be sold worldwide.

Check Discount @ www.factmr.com/connectus/sample?flag=D&rep_id=179

Hospital pharmacies are the largest distribution channel for peptide based cancer therapeutic drugs followed by retail pharmacies. Currently, hospital pharmacies account for close to 50% share of the global market in terms of revenue. The trend is likely to continue in 2017 and beyond.

Competition Tracking

Valeant Pharmaceuticals International, Inc., Allergan plc, AbbVie Inc., AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Abbott, Pfizer Inc., and Johnson & Johnson are among the leading companies functioning in the global market for peptide based cancer therapeutics. Majority of these market players are actively focusing on further product development as well as channelizing their investments in R&D activities.

Click to View Complete Report @ https://www.factmr.com/report/179/peptide-based-cancer-therapeutics-market

About Us

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

Office: Dublin 2

Suite 9884

27 Upper Pembroke Street,

Dublin 2, Ireland

Tel: +353-1-6111-593

( Dublin 2 )

Email: sales@factmr.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Based Cancer Therapeutics Market Estimated to Reach US$ 11,100 Mn by 2022 here

News-ID: 703605 • Views:

More Releases from Fact.MR

U.S. Population Health Management (PHM) Solutions Market Set to Hit US$ 34.59 Billion by 2028 | Fact.MR
04-19-2024 | Health & Medicine
Fact.MR
U.S. Population Health Management (PHM) Solutions Market Set to Hit US$ 34.59 Bi …
The global market for population health management (PHM) solutions in the United States is expected to expand at a compound annual growth rate (CAGR) of 14.8% between 2021 and 2028, according to a recently released Fact.MR analysis. By the end of 2028, the market is projected to reach US$ 34.59 billion. Over the projected period, there is anticipated to be an increase in demand for U.S. Population Health Management (PHM)
Bleaching Clay Market is Anticipated to Grow at a CAGR of 7.2% to Top US$ 1.86 Billion by 2032
Bleaching Clay Market is Anticipated to Grow at a CAGR of 7.2% to Top US$ 1.86 B …
The bleaching clay market was valued at US$ 932.2 million in 2022. Moreover, growth is anticipated to pick up speed at a robust 7.2% CAGR during the evaluation period of 2022-2032, culminating in US$ 1.86 billion. Bleaching clay has been widely utilized for edible oil purification since the nineteenth century. Variations in the yield of oilseed crops are anticipated to positively affect the global market for bleaching clay since bleaching
Automated Microscopy Market to Reach US$ 8.5 Billion by 2027, Grow at a CAGR of 7.5%: Fact.MR
04-19-2024 | Health & Medicine
Fact.MR
Automated Microscopy Market to Reach US$ 8.5 Billion by 2027, Grow at a CAGR of …
According to the most recent analysis conducted by market research and competitive intelligence company Fact.MR, the automated microscopy market is expected to be valued US$ 8.5 billion globally by 2027. With the use of sophisticated monitoring techniques, automated microscopy is a contemporary technology that enhances the monitoring of biological material. In addition to reducing human error, automated microscopy offers accurate, automated magnification for topic examination and analysis. Because automated microscopy is
Toy Drone Market Trends: CAGR of 8.6% Propels Growth to US$ 951.5 Million by 2033
Toy Drone Market Trends: CAGR of 8.6% Propels Growth to US$ 951.5 Million by 203 …
It is Anticipated That the Toy Drone Market Will Reach US$ 951.5 Million by 2033 At A CAGR of 8.6% | Fact.MR growing Children's Propensity for Playing with Drones for Recreation Will Support Market Expansion the global toy drone market is anticipated to reach US$ 417 million in 2023 and develop at a compound annual growth rate (CAGR) of 8.6% over the forecast period of 2023-2033, according to Fact.MR. Because

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top